F. Beau-Salinas

451 total citations
22 papers, 267 citations indexed

About

F. Beau-Salinas is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Pharmacology. According to data from OpenAlex, F. Beau-Salinas has authored 22 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Genetics and 4 papers in Pharmacology. Recurrent topics in F. Beau-Salinas's work include Pharmaceutical studies and practices (5 papers), Drug-Induced Adverse Reactions (4 papers) and Blood disorders and treatments (4 papers). F. Beau-Salinas is often cited by papers focused on Pharmaceutical studies and practices (5 papers), Drug-Induced Adverse Reactions (4 papers) and Blood disorders and treatments (4 papers). F. Beau-Salinas collaborates with scholars based in France, Ivory Coast and Belgium. F. Beau-Salinas's co-authors include A.‐P. Jonville‐Béra, E. Autret‐Leca, Bruno Giraudeau, G Lorette, Florentia Kaguelidou, Évelyne Jacqz-Aigrain, É. Bailly, Jean‐Michel Halimi, Elodie Miquelestorena‐Standley and Marion Marchand and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and American Journal of Kidney Diseases.

In The Last Decade

F. Beau-Salinas

20 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Beau-Salinas France 9 90 76 70 45 37 22 267
Alfredo Cocci Italy 6 38 0.4× 102 1.3× 255 3.6× 11 0.2× 16 0.4× 9 356
Margaux Lafaurie France 10 26 0.3× 40 0.5× 33 0.5× 15 0.3× 13 0.4× 44 288
Laurence Lagarce France 11 58 0.6× 23 0.3× 16 0.2× 27 0.6× 87 2.4× 28 296
N. Partovi Canada 9 44 0.5× 17 0.2× 38 0.5× 49 1.1× 18 0.5× 15 356
Véronique Pinzani France 9 25 0.3× 25 0.3× 32 0.5× 11 0.2× 40 1.1× 21 202
M. Fernández‐Benítez Spain 10 20 0.2× 31 0.4× 73 1.0× 10 0.2× 7 0.2× 23 331
Giuseppe Traversa Italy 11 59 0.7× 14 0.2× 39 0.6× 3 0.1× 20 0.5× 37 304
Samantha Seymour United States 9 42 0.5× 13 0.2× 24 0.3× 2 0.0× 61 1.6× 18 343
Xinyi Jiang United States 11 32 0.4× 38 0.5× 9 0.1× 48 1.1× 48 1.3× 39 304
Arnaud Pagès France 8 20 0.2× 22 0.3× 10 0.1× 46 1.0× 43 1.2× 43 222

Countries citing papers authored by F. Beau-Salinas

Since Specialization
Citations

This map shows the geographic impact of F. Beau-Salinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Beau-Salinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Beau-Salinas more than expected).

Fields of papers citing papers by F. Beau-Salinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Beau-Salinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Beau-Salinas. The network helps show where F. Beau-Salinas may publish in the future.

Co-authorship network of co-authors of F. Beau-Salinas

This figure shows the co-authorship network connecting the top 25 collaborators of F. Beau-Salinas. A scholar is included among the top collaborators of F. Beau-Salinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Beau-Salinas. F. Beau-Salinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beau-Salinas, F., et al.. (2023). Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series. Therapies. 78(6). 705–709. 2 indexed citations
2.
Beau-Salinas, F., et al.. (2023). Case Report of Probable DRESS Syndrome Associated with Ribociclib. SHILAP Revista de lepidopterología. 2023. 1–4. 1 indexed citations
3.
Théophile, Hélène, et al.. (2019). Alitrétinoïne (Toctino®) : données françaises de pharmacovigilance. Therapies. 74(5). 513–519. 3 indexed citations
4.
5.
Bailly, É., F. Beau-Salinas, Laurence Picon, et al.. (2017). Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. American Journal of Kidney Diseases. 71(1). 142–145. 17 indexed citations
6.
Kaguelidou, Florentia, F. Beau-Salinas, A.‐P. Jonville‐Béra, & Évelyne Jacqz-Aigrain. (2016). Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. British Journal of Clinical Pharmacology. 82(4). 1058–1068. 14 indexed citations
7.
Autret‐Leca, E., et al.. (2012). Pharmacovigilance en pédiatrie. Archives de Pédiatrie. 19(8). 848–855. 8 indexed citations
8.
Guilleminault, Laurent, Philippe Carré, F. Beau-Salinas, et al.. (2011). Asthma Unmasked With Tumor Necrosis Factor-α-Blocking Drugs. CHEST Journal. 140(4). 1068–1071. 9 indexed citations
9.
10.
Beau-Salinas, F., et al.. (2009). High doses of deferiprone may be associated with cerebellar syndrome. BMJ. 338(jan22 1). a2319–a2319. 8 indexed citations
11.
Beau-Salinas, F., et al.. (2009). Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European Journal of Clinical Pharmacology. 66(4). 413–417. 10 indexed citations
12.
Jonville‐Béra, A.‐P., et al.. (2009). Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre. Drug Safety. 32(5). 429–440. 27 indexed citations
13.
14.
Jonville‐Béra, A.‐P., et al.. (2005). Implanon® : difficultés d'insertion et de retrait, échecs contraceptifs. Gynécologie Obstétrique & Fertilité. 33(12). 986–990. 29 indexed citations
15.
Merieau, Élodie, et al.. (2005). Métoclopramide et méthémoglobinémie néonatale. Archives de Pédiatrie. 12(4). 438–441. 4 indexed citations
16.
Autret‐Leca, E., et al.. (2005). Pharmacovigilance des vaccins. Archives de Pédiatrie. 13(2). 175–180. 19 indexed citations
17.
Boucraut, José, et al.. (2004). Vascularite cutanée avec atteinte rénale compliquant un traitement par interféron bêta-1a pour une sclérose en plaques. Revue Neurologique. 160(11). 1081–1084. 6 indexed citations
18.
Beau-Salinas, F., et al.. (2003). [Drugs associated with acute generalized exanthematic pustulosis].. PubMed. 130(6-7). 612–8. 52 indexed citations
19.
Jonville‐Béra, A.‐P., et al.. (2002). Frequency of adverse drug reactions in children: A prospective study. British Journal of Clinical Pharmacology. 53(2). 207–210. 43 indexed citations
20.
Jonville‐Béra, A.‐P., et al.. (2001). Les anti-inflammatoires non stéroïdiens favorisent-ils la survenue d'une fasciite nécrosante ?. Archives de Pédiatrie. 8. 473–475. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Cocci Breakdown of academic impact, for papers by Margaux Lafaurie Breakdown of academic impact, for papers by Laurence Lagarce Breakdown of academic impact, for papers by N. Partovi Breakdown of academic impact, for papers by Véronique Pinzani Breakdown of academic impact, for papers by M. Fernández‐Benítez Breakdown of academic impact, for papers by Giuseppe Traversa Breakdown of academic impact, for papers by Samantha Seymour Breakdown of academic impact, for papers by Xinyi Jiang Breakdown of academic impact, for papers by Arnaud Pagès
Rankless by CCL
2026